You just read:

Results of HIV Biologic and Long-Acting Investigational Antiretroviral Ibalizumab to be Presented in Late-Breaker Session at IDWeek 2016™

News provided by

Theratechnologies Inc.

28 Oct, 2016, 10:00 ET